Efalizumab and pulmonary embolism Patient Reports February 11, 2012



Efalizumab Side Effects Report #5453160-8
Efalizumab side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome What is  irritable bowel syndrome and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5472076-4
Efalizumab side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome What is  irritable bowel syndrome and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5486009-8
Efalizumab side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome What is  irritable bowel syndrome and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5490795-0
Efalizumab side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome What is  irritable bowel syndrome and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #5512118-0
Efalizumab side effect was reported by a Physician from UNITED STATES on Oct 29, 2007. Female patient, weighting 175.4 lb, was diagnosed with psoriasis, irritable bowel syndrome What is  irritable bowel syndrome and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 1 MG, 1/WEEK. During the same period patient was treated with TOPICAL STEROID NOS, DYAZIDE, CALCIUM, ALLEGRA D, BENTYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5655656-2
Efalizumab side effect was reported by a Physician from CANADA on Feb 22, 2008. Male patient was diagnosed with psoriasis, psoriatic arthropathy, medical diet, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: psoriasis, pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 0.7 MG/KG, SINGLE. During the same period patient was treated with SULFASALAZINE, DIPROSALIC, GLUCOSAMINE, CAPTOPRIL, FISH OIL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5669762-X
Efalizumab side effect was reported by a Physician from CANADA on Mar 11, 2008. Male patient was diagnosed with psoriasis, psoriatic arthropathy, medical diet, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: psoriatic arthropathy, pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 0.7 MG/KG, SINGLE. During the same period patient was treated with SULFASALAZINE, DIPROSALIC, GLUCOSAMINE, CAPTOPRIL, FISH OIL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5788252-7
Efalizumab side effect was reported by a Physician from CANADA on June 20, 2008. Male patient was diagnosed with psoriasis, psoriatic arthropathy, medical diet, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: hypertension, psoriatic arthropathy, pulmonary embolism What is  pulmonary embolism. Efalizumab dosage: 0.7 MG/KG, SINGLE. During the same period patient was treated with SULFASALAZINE, DIPROSALIC, GLUCOSAMINE, CAPTOPRIL, FISH OIL. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Efalizumab